Online Enquiry
Subscribe
Log in / New User
Retrieve Password
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Log In
|
New User Registration
|
Retrieve Password
Log In
News
TheMarket
IndustryNews
RegulatoryNews
GeneralHealth
Legal/IPRNews
Product/R&DNews
API/BulkDrugNews
PeopleintheNews
OtherNews
TopNewsWorldwide
FEATURE ARTICLES
Editorials
Commentaries
ExpertOpinions
Interviews
CaseStudies
CompanyProfiles
Editor'sPicks
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
NMPA Issues Announcement on Further Strengthening the Drug Distribution Superv...
The NMPA issued the Announcement on Further Strengthening the Drug Distribution Supervision and Management on April 23, aiming to enhance the supervision of drug distribu...
(4/23/2024)
Free Pricing in China for Highly Innovative Me... (4/23/2024)
How BIO CEO's Cozy Relationship with WuXi Sour... (4/19/2024)
China's Drugmakers Can't Sell mRNA Shots But H... (4/19/2024)
A Risky Bet: Zai Lab's Uncertain Future (Seeki... (4/17/2024)
America Hits Chinese Biotech — And Its Own Dr... (4/16/2024)
The Pharmaceutical Playbook for Asia’s Privat... (4/15/2024)
China Biopharma Tracker – Q1 2024 (PharmaDJ) (4/15/2024)
Geopolitics Threatens Chinese Biotechs' Hot Ou... (4/11/2024)
Drugmakers Race to Find Alternative Suppliers ... (4/11/2024)
Biosimilars Coming into Their Own in China, De... (4/10/2024)
CEO Podcast: Hengrui's US Subsidiary's CEO, CM... (4/9/2024)
Foreign Investors Fled Chinese Biotech After t... (4/5/2024)
Novartis Actively Evaluating Ties with C... (4/23/2024)
NMPA Issues Announcement on Further Stre... (4/23/2024)
NMPA Issues the Announcement on Relevant... (4/23/2024)
Drug R&D and Product Registration News D... (4/19/2024)
Recent Executive Moves (4/19/2024)
CDE Publicizes the List of Reference For... (4/18/2024)
CDE Issues the Detailed Rules on Adding ... (4/18/2024)
Andao Pharma/Kind Pharma and Fibrogen Se... (4/18/2024)
China Announces the 2024 Special Rectifi... (4/17/2024)
NMPA Withdraws Approvals for 87 Drug Pro... (4/17/2024)
NMPA Issues the List of Reference Formul... (4/16/2024)
NHC Issues the Guidelines for the Diagno... (4/15/2024)
NHSA: Over 11M Chinese Benefited from Cr... (4/15/2024)
Drug R&D and Product Registration News D... (4/12/2024)
Recent Executive Moves (4/12/2024)
Review of Chinese Online Pharmacy Drug S... (4/12/2024)
PhIIC: Review of Chinese Hospital Drug M... (4/12/2024)
Whooping Cough Resurges in Post-Pandemic... (4/12/2024)
PhIIC: Review of Chinese Hospital Drug Market in 2023
Review of Chinese Online Pharmacy Drug Sales and Leadin...
Generic Drugs Has Experienced Falling Market Share Sinc...
Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023
China Unveils Plans for Market Access and Data Regulati...
Novartis Actively Evaluating Ties with Chinese Contract...
Boehringer Ingelheim and Sino Biopharm Enter Strategic ...
UB and 7th Affiliated Hospital of SYU Launch A Joint Cl...
Rohto and Mitsui to Buy TCM Company for $590M
Genmab A/S to Acquire ADC Developer ProfoundBio for $1....
NMPA Issues the Announcement on Relevant Matters Concer...
NMPA Issues Announcement on Further Strengthening the D...
CDE Issues the Detailed Rules on Adding Pediatric Infor...
CDE Publicizes the List of Reference Formulations for G...
NMPA Withdraws Approvals for 87 Drug Products
China Announces the 2024 Special Rectification Plan for...
NHSA: Over 11M Chinese Benefited from Critical Illness ...
Whooping Cough Resurges in Post-Pandemic China
NHSA's 2023 Healthcare Security Sector Development Stat...
NHSA Disputes Claims of a 'Dropout Wave' in China's Bas...
Andao Pharma/Kind Pharma and Fibrogen Settle on IP Disp...
China Continues to Crackdown on Monopoly and Unfair Mar...
CDE Introduces a Legal Document Submission Module on th...
Narrowly Tailored U.S. Bill Targeting Chinese Biotech C...
Baricitinib's Patent Woes in China: CNIPA Invalidates O...
India Mulls New PLI Scheme to Reduce Chinese API Depend...
FDA Criticizes Chinese API Producer for Deceptive Pract...
US Urges Indian Pharma to Distance from China for APIs ...
Chinese Researchers Makes Breakthrough with Paclitaxel ...
Crescent HiTech to Build New API Facility in Bangladesh...
Drug R&D and Product Registration News Digest April 202...
Drug R&D and Product Registration News Digest April 202...
Review of Class 1 New Drug R&D in China 2018-2023
Ascletis Drops FXR Agonist ASC42 After Disappointing Ph...
Drug R&D and Product Registration News Digest April 202...
BioAtla and BeiGene Revise Global Deal for Novel Condit...
Pfizer to Absorb Mylan, Creating Global Generic Powerho...
PhRMA Calls for Trade Deals That Force Countries to Pay...
IQVIA: Global Pharma to Grow Slower in the Next Five Ye...
Pfizer and GSK Announce JV to Create a Global Consumer ...
Recent Executive Moves
Recent Executive Moves
Recent Official Changes and Executive Moves
Recent Official Changes and Executive Moves
Recent Official and Executive Moves
China Introduces Plan for Pudong New Area's Pilot Compr...
Upcoming Event: 2023 Pharma CI USA Conference & Exhibit...
Upcoming Event: 15th Annual Pharma Market Research Conf...
Upcoming Event: 6th International Conference on Emergin...
Upcoming Event: PHARM Connect Congress
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
2023 Order Form + Product Descripti...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WEEKLY e-ALERT(Premium)
WEEKLY e-ALERT(Basic)
GENERAL INFORMATION
TERMS/CONDITIONS OF USE
PRIVACY STATEMENT
JOIN THE MAILING LIST
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit